Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0004135 (
ATM
)
13,001
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Three of five siblings developed a progressive neurological disorder during infancy or early childhood characterized by cerebellar ataxia, choreoathetosis and peripheral neuropathy. Immunological studies revealed a marked selective deficiency of serum IgE in all three affected siblings. There was evidence of chromosomal instability in the three affected siblings and in one of the parents. One of the affected siblings also developed acute lymphoblastic leukaemia. In spite of many resemblances, this syndrome differs from classical or complete
ataxia telangiectasia
in that oculocutaneous telangiectases were lacking, the serum IgA and
alpha-fetoprotein
levels in this family were normal, there was no gonadal dysgenesis, and the cytogenetic findings were atypical.
...
PMID:Ataxia-without-telangiectasia. Progressive multisystem degeneration with IgE deficiency and chromosomal instability. 659 63
Ataxia telangiectasia
(AT) is an autosomal recessive disorder characterized by telangiectasia, progressive ataxia, sinopulmonary infections and a combined immunodeficiency (usually consisting of IgA deficiency, IgE deficiency, IgG2 and IgG4 deficiency and a disturbed T cell immunity). The
alpha-fetoprotein
level is elevated. Cytogenetic studies reveal a very specific chromosome instability with multiple chromosome 7 and/or 14 rearrangements (preferential breakpoints 14q32, 14q12, 7q35 and 7p12). X-ray hypersensitivity is one of the hallmarks of the disease. Nijmegen Breakage Syndrome (NBS), an autosomal recessive disorder with some features of AT, was first reported in 1981. At this moment at least 19 patients have been recognized. Clinical symptoms are microcephaly from birth, a peculiar face, growth retardation, repeated respiratory tract infections and renal abnormalities. Immunological, cytogenetic and cell-biological findings in NBS are identical to AT. However,
alpha-fetoprotein
levels are not increased. A tendency toward malignancy has been demonstrated in both syndromes. Recently, we encountered three patients with variants of these syndromes.
...
PMID:Variants of Nijmegen breakage syndrome and ataxia telangiectasia. 751 25
Seventeen cases of
ataxia telangiectasia
(AT) were diagnosed over a period of 10 years. The children affected by AT were aged about 7 years and they were preferentially males (67%). The principal clinical aspects were: cerebellous ataxia (98%), recurrent ENT infections (86%) and ocular telangiectasia (96%). We also showed an immune function defect mainly concerning IgA, which was associated with cellular immunity abnormalities (lymphopenia, negative hypersensitivity reactions). The
alpha-fetoprotein
(
AFP
) values were high and increased in proportion to the severity of the neurologic manifestations. Thus, this parameter could be used as a diagnostic index of the illness and could be a precious indicator for the management and the evolution of these patients.
...
PMID:[Ataxia telangiectasia. Clinical and biological study in 17 cases]. 752 81
An 8-year-old girl with severe microcephaly of prenatal onset, borderline intelligence, defects of skin pigmentation, deficiency of both humoral and cellular immunity, a normal serum
alpha-fetoprotein
level and hypersensitivity to ionizing irradiation is described. Spontaneous chromosomal breakage in lymphocytes together with the clinical presentation led to the diagnosis of
ataxia telangiectasia
variant (AT-V). In addition, the patient carried a constitutional translocation of paternal origin: 46,XX,t(3;7)(q12;q31.3) pat. In subsequent linkage and haplotype studies in 12 AT-V families with microsatellite markers from each of the translocation breakpoint regions, we could clearly exclude the localization of an AT-V gene to these regions.
...
PMID:Linkage studies exclude the AT-V gene(s) from the translocation breakpoints in an AT-V patient. 921 78
Ataxia telangiectasia
(AT) is an autosomal recessive disorder characterized by cerebellar ataxia, telangiectasia, immunodeficiency, elevated
alpha-fetoprotein
levels, chromosomal instability, predisposition to cancer, and radiation sensitivity. We report the identification of a new, double missense mutation in the
ataxia telangiectasia
gene (
ATM
) of a Dutch family. This homozygous mutation consists of two consecutive base substitutions in exon 55: a T-->G transversion at position 7875 of the
ATM
cDNA and a G-->C transversion at position 7876. These transversions were confirmed by polymerase chain reaction/primer-induced restriction analysis with CelII. The double base substitution results in an amino acid change of an aspartic acid to a glutamic acid at codon 2625 and of an alanine to a proline at codon 2626 of the ATM protein. Both amino acids are conserved between the ATM protein and its functional homolog, the Atm gene product in the mouse. Furthermore, the Chou-Fasman and Robson predictions both demonstrate a change in the secondary structure of the ATM protein carrying the D2625E/A2626P mutation. These findings suggest that the double base substitution in the
ATM
gene is a disease-causing mutation.
...
PMID:A double missense mutation in the ATM gene of a Dutch family with ataxia telangiectasia. 952 87
Here, we report a familial spinocerebellar ataxia (FSCA), which has clinical features similar to Friedreich's ataxia, an ataxia with isolated vitamin E deficiency, and
ataxia telangiectasia
. However, the serum levels of creatine kinase, gamma-globulin, and
alpha-fetoprotein
were elevated, and biochemical and genetic analyses ruled out diagnosis of these three ataxias as well as other FSCAs. Thus, this family is thought to have a new type of FSCA.
...
PMID:Familial spinocerebellar ataxia with cerebellar atrophy, peripheral neuropathy, and elevated level of serum creatine kinase, gamma-globulin, and alpha-fetoprotein. 970 52
Ataxia-telangiectasia
(AT) is an autosomal recessive multisystem disorder presenting in childhood with progressive cerebellar ataxia, oculocutaneous telangiectasia, immune deficiency, radiosensitivity, and cancer predisposition. The gene for AT, designated
ATM
(AT, mutated) encodes a protein with a carboxy-terminal phosphoinositide-3 kinase domain which is involved in cell cycle checkpoints and other responses to genotoxic stress. Most of the patients with the classical AT phenotype are homozygous or compound heterozygous for severe mutations causing truncation or destabilization of the ATM protein. Patients with a milder forms of disease, called AT variants, have been found to be either homozygous for milder mutations or compound heterozygotes for null alleles and mild mutations. In order to define the clinical phenotype of patients homozygous (or compound heterozygotes) for other, milder mutations, we decided to search for
ATM
mutations in patients with either sporadic or familial idiopathic ataxia. Thirty-four patients with idiopathic cerebellar ataxia, aged 3-77 years, were screened for mutations in the
ATM
coding region. There were 12 familial cases. None of the patients had abnormal immunoglobulin or
alpha-fetoprotein
levels, and none had mutations in the
ATM
coding region. In this heterogeneous group of patients with cerebellar ataxia we found no mutations in the
ATM
gene. We conclude that mutations in the
ATM
gene are probably not a common cause for cerebellar ataxia other than AT.
...
PMID:Absence of mutations in ATM, the gene responsible for ataxia telangiectasia in patients with cerebellar ataxia. 1046 Apr 51
There are no widely applied definitive laboratory tests for the diagnosis of
ataxia telangiectasia
(AT). We, and others, have previously reported significantly elevated levels of in vivo somatic mutation in blood samples from known AT patients, observations that might form the basis for a useful prospective laboratory test for confirmation of a clinical diagnosis of AT. In the present case, a 4 1/2-year-old black female was suspected of having AT based on ataxic gait and chronic upper respiratory infections. Blood work-up showed low IgG2 and elevated
alpha-fetoprotein
(
AFP
), consistent with the AT phenotype. Her peripheral blood karyotype was normal, however, with no spontaneous breakage observed among 100 solid stained metaphases. Lymphocytes from AT patients often show elevated levels of chromosome rearrangement, especially at sites of immunoglobulin and T-cell receptor genes. Therefore, a blood sample was analyzed with the glycophorin A (GPA) in vivo somatic mutation assay. The GPA assay detects and quantifies the phenotypically variant erythrocytes resulting from loss of heterozygosity for the MN blood group. The patient had a 10-fold increased frequency of variant erythrocytes with a phenotype consistent with simple loss of the N allele, which is characteristic of AT. In addition, the variant cell distribution for this patient showed three other, more qualitative hallmarks of AT: a normal frequency of allele loss and duplication events, a unique ridge of cells of intermediate phenotype between the normal and mutant peaks, and evidence of similar ongoing mutational loss of the M allele. Together with clinical data, these distinctive qualitative and quantitative features of the GPA assay allow for a diagnosis of AT with a projected accuracy of 95%. Therefore, we suggest that the GPA assay, which can be performed on < 1 ml of blood and completed in less than a day, be considered as a confirmatory laboratory test for a clinical diagnosis of AT.
...
PMID:Diagnosis of ataxia telangiectasia with the glycophorin A somatic mutation assay. 1046 55
Ataxia telangiectasia
(
A-T
) is a rare autosomal recessive multisystem disease. The diagnosis of
A-T
is based on the typical clinical picture: ataxia and telangiectasia. However, an increase in (
alpha-fetoprotein
(
AFP
) level and the identification of the
A-T
mutated gene (ATM) assist in an early diagnosis. Here we report two cases of
A-T
diagnosed in our hospital (case 1: a 7-year-old boy; case 2: an 8-year-old girl). Both of these patients had typical clinical pictures of ataxia and telangiectasia,
AFP
was also increased (case 1:471.2 ng/dL; case 2: 196 ng/dL). T-cell dysfunction was noted in both patients. Case 1 had IgG2 deficiency and case 2 had IgA, IgG2 and IgG3 deficiency. Case 2 developed malignant lymphoma at 9 years of age and died of pneumonia with respiratory failure at 10 years of age. Because of rhe rarity of
A-T
in Taiwan, we report two cases to help pediatricians make an early diagnosis of
A-T
if they have a patient with progressive ataxia and oculocutaneous telangiectasia.
...
PMID:Ataxia telangiectasia: report of two cases. 1132 Nov 31
Much progress has been made in the early diagnosis of
ataxia-telangiectasia
since the gene was cloned in 1995, A clinical diagnosis can now be confirmed by radiosensitivity testing (colony survival assay), immunoblotting, and mutation detection. The diagnostic value of serum
alpha-fetoprotein
levels and radiosensitivity has been reevaluated using patients with diagnoses based on the presence of mutations in the
ATM
gene and the absence of ATM protein in nuclear extracts. Little progress has been made in treating the progressive ataxia.
...
PMID:Ataxia-telangiectasia: diagnosis and treatment. 1465 5
<< Previous
1
2
3
4
5
Next >>